During the past decade, Cancer Centers of Southwest Oklahoma Research conducted 110 clinical trials. In the 10-year time frame, 110 clinical trials started and 53 clinical trials were completed, i.e. on average, 48.2% percent of trials that started reached the finish line to date. In the past 5 years, 49 clinical trials started and 35 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Centers of Southwest Oklahoma Research" #1 sponsor was "National Cancer Institute (NCI)" with 81 trials, followed by "SWOG Cancer Research Network" with 25 trials sponsored, "Alliance for Clinical Trials in Oncology" with 15 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored and "SCRI Development Innovations, LLC" with 7 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Centers of Southwest Oklahoma Research" #1 collaborator was "National Cancer Institute (NCI)" with 55 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Centers of Southwest Oklahoma Research" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Breast Cancer" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Invasive Breast Carcinoma" (6 trials) and "Recurrent Breast Carcinoma" (6 trials). Many other conditions were trialed in "Cancer Centers of Southwest Oklahoma Research" in a lesser frequency.

Most popular intervention types in "Cancer Centers of Southwest Oklahoma Research" are "Drug" (127 trials), "Other" (93 trials), "Biological" (70 trials), "Procedure" (41 trials) and "Radiation" (24 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (48 trials), "Quality-of-Life Assessment" (40 trials), "Computed Tomography" (28 trials), "Biospecimen Collection" (25 trials) and "Questionnaire Administration" (23 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Centers of Southwest Oklahoma Research" are 128 trials for "All" genders, 17 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Centers of Southwest Oklahoma Research". undefined are not yet recruiting, 46 are recruiting, 67 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Cancer Centers of Southwest Oklahoma Research, 4 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Centers of Southwest Oklahoma Research, 4 "Phase 1" clinical trials were conducted, 76 "Phase 2" clinical trials and 84 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".